NasdaqGS - Delayed Quote • USD
ICU Medical, Inc. (ICUI)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 5:34 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,259,126.00
2,259,126.00
2,279,997.00
1,316,308.00
1,271,004.00
Cost of Revenue
1,519,253.00
1,519,253.00
1,582,236.00
824,818.00
809,507.00
Gross Profit
739,873.00
739,873.00
697,761.00
491,490.00
461,497.00
Operating Expense
692,037.00
692,037.00
701,329.00
350,208.00
325,926.00
Operating Income
47,836.00
47,836.00
-3,568.00
141,282.00
135,571.00
Net Non Operating Interest Income Expense
-95,219.00
-95,219.00
-66,375.00
1,982.00
1,924.00
Other Income Expense
-30,916.00
-30,916.00
-44,466.00
-20,078.00
-40,001.00
Pretax Income
-78,299.00
-78,299.00
-114,409.00
123,186.00
97,494.00
Tax Provision
-48,644.00
-48,644.00
-40,123.00
20,051.00
10,624.00
Net Income Common Stockholders
-29,655.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Diluted NI Available to Com Stockholders
-29,655.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Basic EPS
-1.23
--
-3.11
4.86
4.16
Diluted EPS
-1.23
--
-3.11
4.74
4.02
Basic Average Shares
24,091.00
--
23,868.00
21,206.00
20,907.00
Diluted Average Shares
24,091.00
--
23,868.00
21,781.00
21,591.00
Total Operating Income as Reported
22,825.00
22,825.00
-42,898.00
123,245.00
98,162.00
Total Expenses
2,211,290.00
2,211,290.00
2,283,565.00
1,175,026.00
1,135,433.00
Net Income from Continuing & Discontinued Operation
-29,655.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Normalized Income
-5,100.22
-5,100.22
-43,352.06
120,465.09
125,016.38
Interest Income
7,508.00
7,508.00
4,430.00
2,840.00
3,677.00
Interest Expense
102,727.00
102,727.00
70,805.00
858.00
1,753.00
Net Interest Income
-95,219.00
-95,219.00
-66,375.00
1,982.00
1,924.00
EBIT
24,428.00
24,428.00
-43,604.00
124,044.00
99,247.00
EBITDA
253,202.00
253,202.00
191,547.00
213,742.00
184,878.00
Reconciled Cost of Revenue
1,519,253.00
1,519,253.00
1,582,236.00
824,818.00
809,507.00
Reconciled Depreciation
228,774.00
228,774.00
235,151.00
89,698.00
85,631.00
Net Income from Continuing Operation Net Minority Interest
-29,655.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Total Unusual Items Excluding Goodwill
-31,082.00
-31,082.00
-47,664.00
-20,705.00
-42,813.00
Total Unusual Items
-31,082.00
-31,082.00
-47,664.00
-20,705.00
-42,813.00
Normalized EBITDA
284,284.00
284,284.00
239,211.00
234,447.00
227,691.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-6,527.22
-6,527.22
-16,730.06
-3,374.92
-4,666.62
12/31/2020 - 3/31/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MMSI Merit Medical Systems, Inc.
74.03
-0.20%
UTMD Utah Medical Products, Inc.
67.16
-0.59%
NVST Envista Holdings Corporation
20.28
+0.30%
HAE Haemonetics Corporation
86.22
+1.35%
ANGO AngioDynamics, Inc.
5.87
-2.65%
TFX Teleflex Incorporated
211.17
+0.03%
ATRI Atrion Corporation
424.19
+4.66%
XRAY DENTSPLY SIRONA Inc.
30.92
+0.19%
OSUR OraSure Technologies, Inc.
5.50
-0.54%
LMAT LeMaitre Vascular, Inc.
64.03
-0.31%